Preliminary experience in external quality control of RT-PCR PML-RARα detection in promyelocytic leukemia

被引：0

作者：

P Bolufer

E Barragán

MA Sánz

G Martín

R Bornstein

D Colomer

MD Delgado

M González

I Marugan

J Román

MT Gómez

E Anguita

D Diverio

Ch Chomienne

M Briz

机构：

[1] Laboratorio de Biología Molecular,

[2] Biopatología Clínica,undefined

[3] Unidad de Oncohematología,undefined

[4] Servicio de Hematología,undefined

[5] Hospital Universitario La Fe,undefined

[6] Unidad de Criobiología y Biología Molecular,undefined

[7] Servicio de Hematología,undefined

[8] Hospital 12 de Octubre,undefined

[9] Sección de Hematología,undefined

[10] Area Biología Molecular,undefined

[11] H Clínico De Barcelona,undefined

[12] Biología Molecular,undefined

[13] Hematología,undefined

[14] Hospital Marques de Valdecilla,undefined

[15] Laboratorio de Inmunopatología y Biología Molecular,undefined

[16] Hematología,undefined

[17] H Clínico Universitario,undefined

[18] Laboratorio de Hematología,undefined

[19] Servicio de Hematología y Oncología Médica,undefined

[20] Hospital Clínico Universitario,undefined

[21] Unidad de Biología Molecular,undefined

[22] Hematología,undefined

[23] Hospital Reina Sofía,undefined

[24] Biología Molecular,undefined

[25] Hematología,undefined

[26] H Nuestra Señora del Pino,undefined

[27] Hematología,undefined

[28] Hematología y Hemoterapia,undefined

[29] H Universitario San Carlos,undefined

[30] Laboratorio di Diagnostica Moleculares Oncoematologica,undefined

[31] Sezione Ematologia/Biologia Umana,undefined

[32] Universitá Degli Studi ‘La Sapienza’,undefined

[33] Laboratoire de Biologie Cellulaire Hematopoietique,undefined

[34] Institut d’Hématologie,undefined

[35] Hôpital Saint-Louis,undefined

[36] Biologia Molecular,undefined

[37] Hematologia,undefined

[38] Puerta de Hierro,undefined

来源：

Leukemia | 1998年 / 12卷

关键词：

PML/RARαrearrangement; RT-PCR; external quality assessment; acute promyelocytic leukemia;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

To standardize the results obtained in PML/RARα RT-PCR detection by laboratories of hospitals involved in the Spanish Program for Treatment of Hematological Malignancies (PETHEMA) LPA-96, designed for the treatment of acute promyelocytic leukemia (APL), cDNA samples obtained by reverse transcription of RNA from bone marrow samples of patients with APL were sent to participating laboratories. During the first year of this external quality assessment trial nine samples were tested by a maximum of 12 laboratories. The control gene was satisfactorily amplified in 90% of the samples (62 of 69 samples), supporting the adequacy of the cDNA to be used as control sample. There was an 83% concordance between laboratories for PML/RARα detection with similar results for the type of PML/RRα rearrangements. However, 17% disagreement still remained, attributable to low sensitivity or inadequacy of methods followed. The results stressed the need for implementation of an external quality assessment scheme to ensure the standardization of the results.

引用

页码：2024 / 2028

页数：4

共 50 条

[21] Droplet digital PCR for quantification of PML-RAR in acute promyelocytic leukemia: a comprehensive comparison with real-time PCR
Yuan, Dandan
Cui, Ming
Yu, Shuping
Wang, Huimin
Jing, Rongrong
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2019, 411 (04) : 895 - 903
[22] Differentiation response of acute promyelocytic leukemia cells and PML/RARα leukemogenic activity studies by real-time RT-PCR
Sara Caprodossi
Marika Pedinotti
Consuelo Amantini
Giorgio Santoni
Saverio Minucci
Pier Giuseppe Pelicci
Mirco Fanelli
Molecular Biotechnology, 2005, 30 : 231 - 238
[23] Sentrinization and ubiquitination differentially regulate the fate of PML and PML-RARα in acute promyelocytic leukemia.
Kamitani, T
Yeh, ETH
BLOOD, 1998, 92 (10) : 404A - 404A
[24] Quantitative real-time RT-PCR analysis of PML-RARα-mRNA in acute promyelocytic leukemia:: assessment of prognostic significance in adult patients from intergroup protocol 0129
Gallagher, RE
Yeap, BY
Bi, WL
Livak, KJ
Beaubier, N
Rao, S
Bloomfield, CD
Appelbaum, FR
Tallman, MS
Slack, JL
Willman, CL
BLOOD, 2003, 101 (07) : 2521 - 2528
[25] MiRNA transcription is regulated by the PML-RARα oncoprotein in acute promyelocytic leukemia.
Nigten, Jeannet
Knops, Ruth
Nikoloski, Gorica
de Witte, Theo M.
van der Reijden, Bert A.
Jansen, Joop H.
BLOOD, 2006, 108 (11) : 129B - 129B
[26] PML-RARα inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia
Ohnishi, Kazunori
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2007, 12 (05) : 313 - 317
[27] PML-RARα inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia
Kazunori Ohnishi
International Journal of Clinical Oncology, 2007, 12 : 313 - 317
[28] Cryptic PML-RARα positive acute promyelocytic leukemia with unusual morphology and cytogenetics
Goyal, Manu
Dattatreya, Palinki S.
Goud, Irawathy
Murthy, Sudha S.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2010, 53 (04) : 817 - 819
[29] 实时定量RT-PCR检测PML-RARα融合基因诊断APL的临床价值
陆伟
秦燕
丁润生
尹红
山东医药, 2011, (33) : 13 - 15
[30] Development and validation of a droplet digital PCR assay for the evaluation of PML-RARα fusion transcripts in acute promyelocytic leukemia
Jiang, Xi-wen
Chen, Si-ze
Zhu, Xiao-ya
Xu, Xiao-xie
Liu, Yue
MOLECULAR AND CELLULAR PROBES, 2020, 53

← 1 2 3 4 5 →